发明授权
US5112868A Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl
residues having cyclooxygenase and 5-lipoxygenase inhibition
失效
所选择的具有环加氧酶和5-脂氧合酶抑制的非甾族抗炎酰基残基的羟肟酸衍生物
- 专利标题： Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition
- 专利标题（中）： 所选择的具有环加氧酶和5-脂氧合酶抑制的非甾族抗炎酰基残基的羟肟酸衍生物
-
申请号： US518007申请日： 1990-05-02
-
公开(公告)号： US5112868A公开(公告)日： 1992-05-12
- 发明人: Wiaczeslaw A. Cetenko , David T. Connor , Daniel L. Flynn , Jagadish C. Sircar
- 申请人： Wiaczeslaw A. Cetenko , David T. Connor , Daniel L. Flynn , Jagadish C. Sircar
- 申请人地址： NJ Morris Plains
- 专利权人： Warner-Lambert Company
- 当前专利权人： Warner-Lambert Company
- 当前专利权人地址： NJ Morris Plains
- 主分类号： C07C257/06
- IPC分类号： C07C257/06 ; C07C317/40 ; C07D209/26
摘要：
The present invention is novel selected hydroxamic acid derivatives of acyl residues of selected NSAIDS, i.e. having 5-lipoxygenase and cyclooxygenase inhibiting properties, pharmaceutical compositions for treating conditions advantageously affected by the inhibition and methods for treating these conditions in mammals, including humans suffering therefor.
公开/授权文献
- US6075817A Compressive communication and storage system 公开/授权日：2000-06-13
信息查询
